ATE112317T1 - Bcrf1-proteine als inhibitoren von interferon- g(g). - Google Patents
Bcrf1-proteine als inhibitoren von interferon- g(g).Info
- Publication number
- ATE112317T1 ATE112317T1 AT91902258T AT91902258T ATE112317T1 AT E112317 T1 ATE112317 T1 AT E112317T1 AT 91902258 T AT91902258 T AT 91902258T AT 91902258 T AT91902258 T AT 91902258T AT E112317 T1 ATE112317 T1 AT E112317T1
- Authority
- AT
- Austria
- Prior art keywords
- interferon
- inhibitors
- bcrf1
- proteins
- bcrf1 proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/141—Interleukin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45393189A | 1989-12-20 | 1989-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE112317T1 true ATE112317T1 (de) | 1994-10-15 |
Family
ID=23802631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91902258T ATE112317T1 (de) | 1989-12-20 | 1990-12-18 | Bcrf1-proteine als inhibitoren von interferon- g(g). |
Country Status (27)
Country | Link |
---|---|
US (2) | US5627155A (de) |
EP (1) | EP0506836B1 (de) |
JP (1) | JP2648236B2 (de) |
KR (1) | KR960015199B1 (de) |
CN (1) | CN1057012C (de) |
AT (1) | ATE112317T1 (de) |
AU (1) | AU7899694A (de) |
CA (1) | CA2071907C (de) |
CZ (1) | CZ283049B6 (de) |
DE (1) | DE69013011T2 (de) |
DK (1) | DK0506836T3 (de) |
ES (1) | ES2064082T3 (de) |
FI (1) | FI104883B (de) |
HK (1) | HK185396A (de) |
HU (1) | HU215909B (de) |
IE (1) | IE72203B1 (de) |
IL (1) | IL96715A0 (de) |
MX (1) | MX9203409A (de) |
MY (1) | MY107449A (de) |
NO (1) | NO305703B1 (de) |
NZ (1) | NZ236512A (de) |
OA (1) | OA09703A (de) |
PH (1) | PH31669A (de) |
PT (1) | PT96231B (de) |
SK (1) | SK635190A3 (de) |
WO (1) | WO1991009127A1 (de) |
ZA (1) | ZA9010188B (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
JPH04505019A (ja) * | 1989-10-23 | 1992-09-03 | シェリング・コーポレーション | ガンマインターフェロンのポリペプチド性阻害剤 |
DE69201128T2 (de) * | 1991-01-16 | 1995-05-24 | Schering Corp | Behandlung von neoplastischen krankenheiten mit interleukin-10. |
US6106823A (en) * | 1991-01-16 | 2000-08-22 | Schering Corporation | Treatment of neoplastic disease with interleukin-10 |
KR100271197B1 (ko) * | 1991-08-06 | 2000-11-01 | 둘락 노먼 씨. | 인터루킨-10동족체또는길항제를포함하는내독소-또는초항원유도된독성치료용의약제학적조성물 |
US5833976A (en) * | 1991-08-06 | 1998-11-10 | Schering Corporation | Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity |
DK1225226T3 (da) * | 1992-03-13 | 2008-04-14 | Biomerieux Bv | Peptider og nucleinsyresekvenser beslægtet med Epstein-Barr-virus |
US6008327A (en) * | 1992-03-13 | 1999-12-28 | Akzo Nobel, N.V. | Peptides and nucleic acid sequences related to the Epstein Barr virus |
AU3801193A (en) * | 1992-03-20 | 1993-10-21 | Schering Corporation | Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist |
EP0726315B1 (de) * | 1993-07-23 | 2001-10-17 | Hans Prof. Dr. Wolf | DNA-Sequenzen des Epstein-Barr Virus kodierend für ein diagnostisch relevantes Virus-Hüllprotein, durch PCR erhaltene Expressionsklone und Verwendung dieses rekombinanten Antigens in diagnostischen Tests |
US5616724A (en) * | 1996-02-21 | 1997-04-01 | Cephalon, Inc. | Fused pyrrolo[2,3-c]carbazole-6-ones |
ATE413881T1 (de) * | 1997-08-08 | 2008-11-15 | Celmed Oncology Usa Inc | Verfahren und zubereitungen um resistenz gegen biologische oder chemische therapien zu überwinden |
CN104159919A (zh) | 2011-11-23 | 2014-11-19 | 安姆根有限公司 | 使用抗干扰素γ抗体的治疗方法 |
WO2022016509A1 (zh) * | 2020-07-24 | 2022-01-27 | 阎忠扬 | 一种用以筛选药物的方法,以及该药物用于治疗牛皮癣的用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3583564D1 (de) * | 1984-08-23 | 1991-08-29 | Hans Joachim Wolf | Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten. |
US5256768A (en) * | 1985-12-13 | 1993-10-26 | The Johns Hopkins University | Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics |
-
1990
- 1990-12-18 MX MX9203409A patent/MX9203409A/es unknown
- 1990-12-18 DE DE69013011T patent/DE69013011T2/de not_active Expired - Fee Related
- 1990-12-18 ZA ZA9010188A patent/ZA9010188B/xx unknown
- 1990-12-18 EP EP91902258A patent/EP0506836B1/de not_active Expired - Lifetime
- 1990-12-18 HU HU9202075A patent/HU215909B/hu not_active IP Right Cessation
- 1990-12-18 CZ CS906351A patent/CZ283049B6/cs not_active IP Right Cessation
- 1990-12-18 CA CA002071907A patent/CA2071907C/en not_active Expired - Fee Related
- 1990-12-18 WO PCT/US1990/007288 patent/WO1991009127A1/en active IP Right Grant
- 1990-12-18 DK DK91902258.2T patent/DK0506836T3/da active
- 1990-12-18 SK SK6351-90A patent/SK635190A3/sk unknown
- 1990-12-18 AT AT91902258T patent/ATE112317T1/de not_active IP Right Cessation
- 1990-12-18 JP JP3502513A patent/JP2648236B2/ja not_active Expired - Fee Related
- 1990-12-18 IL IL96715A patent/IL96715A0/xx unknown
- 1990-12-18 NZ NZ236512A patent/NZ236512A/en unknown
- 1990-12-18 PH PH41744A patent/PH31669A/en unknown
- 1990-12-18 PT PT96231A patent/PT96231B/pt not_active IP Right Cessation
- 1990-12-18 KR KR1019920701474A patent/KR960015199B1/ko not_active IP Right Cessation
- 1990-12-18 ES ES91902258T patent/ES2064082T3/es not_active Expired - Lifetime
- 1990-12-19 IE IE458890A patent/IE72203B1/en not_active IP Right Cessation
- 1990-12-19 CN CN90110079A patent/CN1057012C/zh not_active Expired - Fee Related
- 1990-12-19 MY MYPI90002207A patent/MY107449A/en unknown
-
1992
- 1992-06-16 FI FI922770A patent/FI104883B/fi active
- 1992-06-19 OA OA60232A patent/OA09703A/en unknown
- 1992-06-19 NO NO922456A patent/NO305703B1/no not_active IP Right Cessation
-
1994
- 1994-11-23 AU AU78996/94A patent/AU7899694A/en not_active Abandoned
-
1995
- 1995-05-26 US US08/450,749 patent/US5627155A/en not_active Expired - Lifetime
- 1995-06-06 US US08/466,950 patent/US5736390A/en not_active Expired - Lifetime
-
1996
- 1996-01-03 HK HK185396A patent/HK185396A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0335901A4 (en) | Methods and compositions for the treatment of non-ige-mediated diseases | |
ES8602768A1 (es) | Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas. | |
ATE112317T1 (de) | Bcrf1-proteine als inhibitoren von interferon- g(g). | |
ATE202706T1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
RO90639B (ro) | Procedeu pentru prepararea tesutului uman activator de plasminogen | |
FI935585A0 (fi) | Pyrrolopyrimidiner | |
ATE246248T1 (de) | Anti-hiv-proteine gap31, dap30 und dap32, die sie kodierende dna und ihre therapeutische nutzung | |
DE69130679D1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
MX9304070A (es) | Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol. | |
ES2066096T3 (es) | 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos. | |
HUP9901161A2 (hu) | Módosított aktivitású hibrid VIII. faktor | |
FI922428A0 (fi) | Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
ATE168698T1 (de) | Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten | |
IL99940A0 (en) | Beta-galactoside binding proteins,methods for the production thereof,and pharmaceutical compositions containing the same | |
DK0656889T3 (da) | 9-chlorprostaglandinestere og -amider og deres anvendelse ved fremstilling af lægemidler | |
MX9700113A (es) | Amido-quinoxalindionas novedosas, su preparacion y uso. | |
TR199800850T2 (xx) | Kan� d�zenleyici bile�imler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |